Target intelligence / Profile preview

Homeobox protein SIX3 (SIX3)

Target
SIX3
Molecular classification
Transcription factor, Homeobox protein
01

Overview

Homeobox protein SIX3 (SIX3) is a transcription factor belonging to the sine oculis homeobox family, crucial for embryonic development, particularly for the formation of the forebrain and the eyes. SIX3 functions by binding specific DNA sequences, acting as both a transcriptional activator and repressor. It regulates multiple genes and pathways central to neural and ocular development, including direct activation of the Sonic Hedgehog (SHH) gene and repression of genes such as WNT1 and WNT8B. SIX3 also directly activates PAX6, a key regulator of eye formation, and plays a vital role in cell proliferation, cell fate specification, and tissue morphogenesis in neural and ocular tissues. Mutations in SIX3 can cause holoprosencephaly type 2 (HPE2), where the forebrain fails to properly divide, leading to severe brain and craniofacial abnormalities. Key interactions include transcriptional regulation of genes involved in anterior brain patterning, and interaction with coregulatory proteins such as TLE1 and Neuron-derived orphan receptor 1. SIX3 is not considered a direct therapeutic drug target, but its genetic variants are clinically significant as biomarkers for early-onset developmental diseases, and dysregulation may play a role in oncogenic processes.

Other names
SIX homeobox 3Sine oculis homeobox homolog 3HPE2sine oculis homeobox-like protein 3
02

Biological functions

Regulation of embryonic developmentEye developmentForebrain developmentTranscriptional activation and repressionRegulation of cell proliferation and differentiationPituitary gland developmentRetinal and lens formation
03

Disease associations

Holoprosencephaly type 2SchizencephalyNeurodevelopmental disordersCancer (role in tumorigenesis suggested but not directly targeted in therapy)
04

Safety considerations

not a therapeutic target, but loss-of-function mutations cause developmental defects in brain and eye
05

Biomarkers

Mutations in SIX3 as a genetic marker for holoprosencephaly type 2 (HPE2)

Beyond the preview

Go deeper on Homeobox protein SIX3 (SIX3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Homeobox protein SIX3 (SIX3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call